← Back to patent-cliff list
CAS 154235-77-5
benzo[d]oxazole-6-carboxylic acid
Codes: TAFA-006
Application context (from source-drug indications)
Amyloid polyneuropathyTafamidis MeglumineTransthyretin amyloidosisTafamidis MeglumineAmyloidosisTafamidis MeglumineCardiomyopathyTafamidis MeglumineLight-chain (AL) amyloidosisTafamidis MeglumineFamilial amyloid neuropathyTafamidis Meglumine
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Tafamidis Meglumine | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-amino-3-hydroxybenzoic acid→benzo[d]oxazole-6-carboxylic acid→benzo[d]oxazol-6-yl(morpholino)methanone→1,3-dichloro-5-iodobenzene→(2-(3,5-dichlorophenyl)benzo[d]oxazol-6-yl)(morpholino)methanone
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.